Coxon Fraser P, Thompson Keith, Roelofs Anke J, Ebetino F Hal, Rogers Michael J
Bone & Musculoskeletal Programme, Institute of Medical Sciences, University of Aberdeen, Foresterhill, Aberdeen, AB25 2ZD, UK.
Bone. 2008 May;42(5):848-60. doi: 10.1016/j.bone.2007.12.225. Epub 2008 Jan 26.
Bisphosphonates (BPs) target bone due to their high affinity for calcium ions. During osteoclastic resorption, these drugs are released from the acidified bone surface and taken up by osteoclasts, where they act by inhibiting the prenylation of small GTPases essential for osteoclast function. However, it remains unclear exactly how osteoclasts internalise BPs from bone and whether other cells in the bone microenvironment can also take up BPs from the bone surface. We have investigated this using a novel fluorescently-labelled alendronate analogue (FL-ALN), and by examining changes in protein prenylation following treatment of cells with risedronate (RIS). Confocal microscopic analysis showed that FL-ALN was efficiently internalised from solution or from the surface of dentine by resorbing osteoclasts into intracellular vesicles. Accordingly, unprenylated Rap1A accumulated to the same extent whether osteoclasts were cultured on RIS-coated dentine or with RIS in solution. By contrast, J774 macrophages internalised FL-ALN and RIS from solution, but took up comparatively little from dentine, due to their inability to resorb the mineral. Calvarial osteoblasts and MCF-7 tumour cells internalised even less FL-ALN and RIS, both from solution and from the surface of dentine. Accordingly, the viability of J774 and MCF-7 cells was drastically reduced when cultured with RIS in solution, but not when cultured on dentine pre-coated with RIS. However, when J774 macrophages were co-cultured with rabbit osteoclasts, J774 cells that were adjacent to resorbing osteoclasts frequently internalised more FL-ALN than J774 cells more distant from osteoclasts. This was possibly a result of increased availability of BP to these J774 cells due to transcytosis through osteoclasts, since FL-ALN partially co-localised with trancytosed, resorbed matrix protein within osteoclasts. In addition, J774 cells occupying resorption pits internalised more FL-ALN than those on unresorbed surfaces. These data demonstrate that osteoclasts are able to take up large amounts of BP, due to their ability to release the BP from the dentine surface during resorption. By contrast, non-resorbing cells take up only small amounts of BP that becomes available due to natural desorption from the dentine surface. However, BP uptake by non-resorbing cells can be increased when cultured in the presence of resorbing osteoclasts.
双膦酸盐(BPs)因其对钙离子具有高亲和力而作用于骨骼。在破骨细胞吸收过程中,这些药物从酸化的骨表面释放出来并被破骨细胞摄取,在破骨细胞中,它们通过抑制对破骨细胞功能至关重要的小GTP酶的异戊二烯化发挥作用。然而,目前尚不清楚破骨细胞究竟如何从骨中摄取双膦酸盐,以及骨微环境中的其他细胞是否也能从骨表面摄取双膦酸盐。我们使用一种新型的荧光标记阿仑膦酸盐类似物(FL-ALN),并通过检测用利塞膦酸盐(RIS)处理细胞后蛋白质异戊二烯化的变化来对此进行了研究。共聚焦显微镜分析表明,FL-ALN可通过吸收性破骨细胞有效地从溶液或牙本质表面内化到细胞内囊泡中。因此,无论破骨细胞是在涂有RIS的牙本质上培养还是在溶液中与RIS一起培养,未异戊二烯化的Rap1A积累程度相同。相比之下,J774巨噬细胞从溶液中摄取FL-ALN和RIS,但由于它们无法吸收矿物质,从牙本质中摄取的量相对较少。颅骨成骨细胞和MCF-7肿瘤细胞从溶液和牙本质表面摄取的FL-ALN和RIS更少。因此,当J774和MCF-7细胞在溶液中与RIS一起培养时,其活力会急剧降低,但在预先涂有RIS的牙本质上培养时则不会。然而,当J774巨噬细胞与兔破骨细胞共培养时,与吸收性破骨细胞相邻的J774细胞通常比距离破骨细胞较远的J774细胞摄取更多的FL-ALN。这可能是由于通过破骨细胞的转胞吞作用使这些J774细胞获得的双膦酸盐可用性增加,因为FL-ALN与破骨细胞中转胞吞的、吸收的基质蛋白部分共定位。此外,占据吸收凹坑的J774细胞比未吸收表面上的细胞摄取更多的FL-ALN。这些数据表明,破骨细胞能够摄取大量的双膦酸盐,这是因为它们在吸收过程中能够从牙本质表面释放双膦酸盐。相比之下,非吸收性细胞仅摄取少量因从牙本质表面自然解吸而可得的双膦酸盐。然而,当在有吸收性破骨细胞存在的情况下培养时,非吸收性细胞对双膦酸盐的摄取可以增加。